Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Cascade Biocatalysts

start up
United States - Denver, Colorado
  • 23/08/2023
  • Pre-Seed
  • $2,600,000

Cascade Biocatalysts is creating more productive enzymes for economical biomanufacturing of sustainable chemicals. Cascade addresses the growing need for stable, long-lasting biocatalysts using our patent-pending enzyme immobilization platform. By combining nature’s catalyst, enzymes, with state-of-the-art materials, we can create something that is greater than the sum of its parts. Join us as we help build the future bioeconomy.


Related People

Alex RosayCo Founder

Alex Rosay United States - Brooklyn, New York

My interests lie at the intersection of life sciences, technology, and business, and I am betting my career on the biorevolution and the emerging bioeconomy. Currently I am building Cascade Biocatalysts with the dream of easy-to-use enzymes that are both economical and scalable for greener chemical manufacturing.

Before leading Cascade, I was a product manager for the computational product discovery team at Zymergen, focused on using software and data science tools to accelerate new molecule discovery from biology.

Before Zymergen, my experience as an associate at Bain & Company coupled with my technical education as a chemical engineer at Stanford and the Dow Chemical company provided me a unique skill which has allowed me to excel at the interface of technology and business.